NCT05566626

Brief Summary

An explorative study of the Mantis Photonics hyperspectral camera for retinal imaging and estimation of retinal oxygenation. Primary objective: To evaluate the performance of the hyperspectral camera for non-invasive retinal examination in order to improve the diagnosis of diseases affecting the retina or central nervous system. Secondary objective: To investigate the possibilities of the use of a hyperspectral camera for non-invasive retinal examination.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 22, 2022

Completed
9 days until next milestone

Study Start

First participant enrolled

October 1, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 4, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

October 21, 2022

Status Verified

October 1, 2022

Enrollment Period

1.1 years

First QC Date

September 22, 2022

Last Update Submit

October 20, 2022

Conditions

Keywords

hyperspectralretinoscopyoxygenationnon-invasive

Outcome Measures

Primary Outcomes (1)

  • Performance evaluation - Retinal Oxygenation

    Measurement of retinal oxygenation for each patient: hemoglobin oxygenation of retinal artery \[in percent\] hemoglobin oxygenation of retinal vein \[in percent\] Measurement: calculated result based on the hyperspectral reflectance profile of vein and artery regions of the retina.

    During the procedure (retinoscopy with hyperspectral camera).

Secondary Outcomes (1)

  • Retinal examination exploration - detection of macular degeneration

    After the procedure (retinoscopy with hyperspectral camera). Manual evaluation in the week after the procedure.

Other Outcomes (2)

  • Adverse effect

    Immediately after the retinoscopy procedure.

  • Serious adverse effect

    Immediately after the retinoscopy procedure.

Study Arms (1)

Camera test group

EXPERIMENTAL

The Principal Investigator will take a hyperspectral image of all subjects, both healthy volunteers and patients.

Device: Hyperspectral retinal imageDrug: Mydriacyl Ophthalmic Product

Interventions

Hyperspectral image of both eyes

Also known as: hyperspectral retinoscopy
Camera test group

Mydriatic drops before retinoscopy

Camera test group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
For inclusion in the investigation, the patient-subjects must fulfill all of the below criteria prior to enrollment: 1. Age \> 18 years. 2. Ophthalmological disease, disorder, illness or problem involving the retina 3. Provision of informed consent i.e., subject must be able to understand and sign the patient information and consent form. For inclusion in the investigation, the healthy subjects must fulfill all of the below criteria prior to enrollment: 1. Age \>18 years. 2. Without known eye disease. 3. Provision of informed consent i.e., subject must be able to understand and sign the patient information and consent form. Patients-subjects who meet any of the below criteria will be excluded from the investigation: 1. Patients with narrow angle glaucoma 2. Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the Principal Investigator. Healthy subjects who meet any of the below criteria will be excluded from the investigation: 1\. Presence of eye disease, eye trauma, diabetes or pregnancy. 3. Inclusion in other ongoing investigations at present that would preclude the subject from participating in this investigation as judged by the Principal Investigator.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

Sundets Ögonläkare

Helsingborg, Skåne County, 252 21, Sweden

Location

Related Publications (8)

  • Bernardes R, Serranho P, Lobo C. Digital ocular fundus imaging: a review. Ophthalmologica. 2011;226(4):161-81. doi: 10.1159/000329597. Epub 2011 Sep 22.

    PMID: 21952522BACKGROUND
  • Hardarson SH, Stefansson E, Bek T. Retinal oxygen saturation changes progressively over time in diabetic retinopathy. PLoS One. 2021 May 12;16(5):e0251607. doi: 10.1371/journal.pone.0251607. eCollection 2021.

    PMID: 33979414BACKGROUND
  • Johnson WR, Wilson DW, Fink W, Humayun M, Bearman G. Snapshot hyperspectral imaging in ophthalmology. J Biomed Opt. 2007 Jan-Feb;12(1):014036. doi: 10.1117/1.2434950.

    PMID: 17343511BACKGROUND
  • Lee EJ, Kee HJ, Han JC, Kee C. Evidence-based understanding of disc hemorrhage in glaucoma. Surv Ophthalmol. 2021 May-Jun;66(3):412-422. doi: 10.1016/j.survophthal.2020.09.001. Epub 2020 Sep 17.

    PMID: 32949554BACKGROUND
  • Lu G, Fei B. Medical hyperspectral imaging: a review. J Biomed Opt. 2014 Jan;19(1):10901. doi: 10.1117/1.JBO.19.1.010901.

    PMID: 24441941BACKGROUND
  • Meinke M, Muller G, Helfmann J, Friebel M. Empirical model functions to calculate hematocrit-dependent optical properties of human blood. Appl Opt. 2007 Apr 1;46(10):1742-53. doi: 10.1364/ao.46.001742.

    PMID: 17356617BACKGROUND
  • Ohno-Matsui K. Parallel findings in age-related macular degeneration and Alzheimer's disease. Prog Retin Eye Res. 2011 Jul;30(4):217-38. doi: 10.1016/j.preteyeres.2011.02.004. Epub 2011 Mar 25.

    PMID: 21440663BACKGROUND
  • Safi H, Safi S, Hafezi-Moghadam A, Ahmadieh H. Early detection of diabetic retinopathy. Surv Ophthalmol. 2018 Sep-Oct;63(5):601-608. doi: 10.1016/j.survophthal.2018.04.003. Epub 2018 Apr 19.

    PMID: 29679616BACKGROUND

MeSH Terms

Conditions

Macular DegenerationRetinal Detachment

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Officials

  • Madeleine Selvander, MD

    Sundets Ögonläkare

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: Alle participants, both healthy subjects and patients, receive the same intervention: hyperspectral image with Mantis Photonics camera
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 22, 2022

First Posted

October 4, 2022

Study Start

October 1, 2022

Primary Completion

November 1, 2023

Study Completion

December 1, 2023

Last Updated

October 21, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

No Individual Participant Data (IPD) sharing to third parties. Data of individual participants will be used for this study only.

Locations